Dynamics of Total, Linear Nonintegrated, and Integrated HIV‐1 DNA In Vivo and In Vitro-Reference-Cited by-同舟云学术

Dynamics of Total, Linear Nonintegrated, and Integrated HIV‐1 DNA In Vivo and In Vitro

Published:2008-02 Issue:3 Volume:197 Page:411-419
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Koelsch Kersten K.,Liu Lin,Haubrich Richard,May Susanne,Havlir Diane,Günthard Huldrych F.,Ignacio Caroline C.,Campos‐Soto Paula,Little Susan J.,Shafer Robert,Robbins Gregory K.,D’Aquila Richard T.,Kawano Yuji,Young Karen,Dao Phillip,Spina Celsa A.,Richman Douglas D.,Wong Joseph K.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference44 articles.

1. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

2. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

3. Predictors of Residual Viremia in HIV‐Infected Patients Successfully Treated with Efavirenz and Lamivudine plus either Tenofovir or Stavudine

4. Prognostic Value of Baseline Human Immunodeficiency Virus Type 1 DNA Measurement for Disease Progression in Patients Receiving Nucleoside Therapy

5. Level of Human Immunodeficiency Virus DNA in Peripheral Blood Mononuclear Cells Correlates with Efficacy of Antiretroviral Therapy

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 Vpr Functions in Primary CD4+ T Cells;Viruses;2024-03-09

2. Factors associated with unquantifiable total HIV-1 DNA in peripheral blood in persons living with HIV: An observational study;Journal of Virus Eradication;2024-03

3. HIV-1 resistance mutations to integrase inhibitors impair both integration and reverse transcription steps;International Journal of Antimicrobial Agents;2024-01

4. Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation;AIDS;2023-11-28

5. Raltegravir Plus Nucleoside Reverse-Transcriptase Inhibitor (NRTI) Plus Lopinavir, NRTIs Plus Lopinavir for Second-Line Treatment of HIV: 96-Week Follow-up Results from a Randomized Controlled Trial;J BIOL REG HOMEOS AG;2023